Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’
CNBC traders picked WST, JPM, META and IYE; analysts raised WST and META targets, while JPM missed Q3 earnings and revenue estimates.
Stocks · News reference
CNBC Halftime Report Final Trades: JP Morgan Chase & Co., Meta Platforms, West Pharmaceutical Services, iShares U.S. Energy ETF
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Overweight on JPMorgan Chase, Raises Price Target to $425
Barclays analyst Jason Goldberg maintains JPMorgan Chase (NYSE:JPM) with a Overweight and raises the price target from $420 to $425.
RBC Capital Reiterates Outperform on JPMorgan Chase, Maintains $370 Price Target
RBC Capital analyst Gerard Cassidy reiterates JPMorgan Chase (NYSE:JPM) with a Outperform and maintains $370 price target.
JPMorgan Analysts Boost Their Forecasts After Q3 Results
JPMorgan misses Q3 earnings and revenue estimates; shares dip 1.3% as analysts lift price targets and company forecasts 2027 NII growth.
Meta To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts raised targets for ACI, ORIC, JPM, SHOP, META and U; KTB upgraded to Buy. Domino’s target was cut.
Watching Zoom Communications; Shares See Volume To The Downside After Meta Announces Now You Can Invite Anyone To A WhatsApp Call, Even If They Don’t Have A WhatsApp Account